CRYSTALLINE FORMS OF (9R, 135S)-13- {4-[5-CHLORO-2-(4-CHLORO-1H,2,3- TRIAZOL- 1 -YL)PHENYL] -6-OXO- 1,6-DIHYDROPYRIMIDIN- 1-YL}-3-(DIFLUOROMETHYL)-9-METHYL-3,4,7,15- TETRAAZATRICYCLO [ 12.3.1.0 2*6] OCTADECA- 1(18), 2(6), 4, 14, 16-PENTAEN-8-ONE | Patent Publication Number 20230151010
US 20230151010 A1Publication DateMay 18, 2023
Original Assignee
Current AssigneeJanssen Pharmaceuticals Johnson & Johnson
Inventor/ApplicantsDavid Ludeker
Michael A. Galella
Daniel Smith
Dirk Angelina J. CLEEREN
Christos XIOURAS
Theresa M. Ziemba
Dipali AHUJA
Andrew K. Dilger
Michael A. Galella
Daniel Smith
Dirk Angelina J. CLEEREN
Christos XIOURAS
Theresa M. Ziemba
Dipali AHUJA
Andrew K. Dilger
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.